Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:developedBy |
UDP-003
|
| gptkbp:focusesOn |
senolytic drugs
treatment of age-related diseases |
| gptkbp:foundedIn |
2019
|
| gptkbp:founder |
gptkb:Matthew_O'Connor
gptkb:Aubrey_de_Grey |
| gptkbp:fundedBy |
gptkb:Kizoo_Technology_Capital
gptkb:SENS_Research_Foundation |
| gptkbp:headquartersLocation |
gptkb:Mountain_View,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Underdog Pharmaceuticals
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:mission |
to develop therapies targeting toxic oxidized cholesterol derivatives
|
| gptkbp:notableWork |
removal of 7-ketocholesterol
|
| gptkbp:parentOrganization |
gptkb:SENS_Research_Foundation
|
| gptkbp:website |
https://underdogpharma.com/
|
| gptkbp:bfsParent |
gptkb:Cyclarity_Therapeutics
|
| gptkbp:bfsLayer |
7
|